Paasa Logo
MiNK Therapeutics, Inc. logo
INKTNASDAQMarket openCloses 4:00pm ET

MiNK Therapeutics, Inc.

$12.14Last updated
+$0.03 (0.21%)Past day
Timezone

MiNK Therapeutics, Inc. (NASDAQ: INKT) is trading at $12.14, about ₹1,166 at today's USD/INR rate, as of 29 Sep 2026, 10:12 AM ET, up 0.21% today. Indian residents can buy MiNK Therapeutics from India on Paasa under the RBI's Liberalised Remittance Scheme.

Quote

Open:$12.18
Previous close:$12.11
Volume:4.44K

Today's low

$12.09

Today's high

$12.69

52 week low

$8.48

52 week high

$16.93

INKT opened at $12.18, closed previously at $12.11, and has traded between $8.48 and $16.93 over the past 52 weeks.

About

MiNK Therapeutics, Inc. is a biopharmaceutical firm currently undergoing clinical trials. Its primary focus is on the identification, advancement, and market introduction of innovative invariant natural killer T (iNKT) cell therapies. These treatments are allogeneic and designed to be "off-the-shelf," providing readily available options for combating various cancers and conditions rooted in immune system dysfunction. The company's leading investigational therapy is AGENT-797. This product is an allogeneic, ready-to-use iNKT cell therapy, presently in Phase 1 clinical studies to assess its effectiveness against different forms of myeloma. Established in 2017, the company was previously known as AgenTus Therapeutics, Inc. MiNK Therapeutics, Inc. is headquartered in New York, New York, and operates as a subsidiary of Agenus Inc.

Country
US
CEO
Jennifer S. Buell
Exchange listed on
NASDAQ
Industry
Biotechnology
Base currency
USD
Full Time Employees
15
Sector
Healthcare
IPO date
15/10/2021

Key statistics

Avg. volume

20.43K

Market cap

$60.46M

P/E Ratio

-5.08

Price-to-sales ratio

0.00

Enterprise value

$51.65M

Free cash flow yield

-3452.80%

Debt-to-equity ratio

0.00

Return on equity

83.45%

ROIC

-604.20%

Beta

0.49

Dividend yield

0.00%

Last dividend

$0.00

Financial overview

Revenue

$0.00

Earnings per share

-$2.93

Free cash flow

-$5.93M

Net profit margin

0.00%

Gross margin

0.00%

EBITDA

-$12.31M

Revenue growth

—

Similar securities

This is not an investment recommendation

How to buy MiNK Therapeutics from India

Indian residents can buy MiNK Therapeutics shares through Paasa in four steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name with Interactive Brokers.

  1. Open a Paasa account

    Complete digital KYC with your PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.

  2. Add funds under LRS

    Transfer INR from your Indian bank account. Your bank reports the remittance under the RBI's Liberalised Remittance Scheme and converts it to US dollars.

  3. Search for MiNK Therapeutics and place an order

    Find MiNK Therapeutics by name or by its ticker, INKT, and choose an order type. You can buy by amount or by quantity — fractional shares mean there is no minimum trade size. MiNK Therapeutics trades 7:00 pm – 1:30 am IST; orders can only execute during that window.

  4. Track holdings and download tax reports

    Follow your MiNK Therapeutics position in USD and INR. MiNK Therapeutics pays no dividend today, so your filing is the capital-gains statement plus the Schedule FA holding line.

Read the full guide: how to invest in MiNK Therapeutics from India

Trading and taxes when buying MiNK Therapeutics from India

Trading and limits

Trading hours
9:30 am – 4:00 pm ET
LRS limit
$250,000Per financial year, under the RBI's Liberalised Remittance Scheme.

Tax for Indian residents

TCS on remittance
20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
Capital gains in India
12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
Dividends
NoneMiNK Therapeutics does not currently pay a dividend. If it starts, dividends are taxed at your slab rate in India.Dividend tax explained
US estate tax
May applyUS-situs assets such as US-listed shares can be exposed to US estate tax for non-US persons.US estate tax calculator

Custody. Shares are held in your own name at Interactive Brokers LLC and are SIPC-insured up to $500,000 in total, including $250,000 for cash.

FAQs

Can Indian residents buy MiNK Therapeutics stock?

Yes. MiNK Therapeutics (INKT) has been listed on NASDAQ since 2021, in the Biotechnology industry, and Indian residents can buy it through Paasa. You fund the account from your Indian bank under the RBI's Liberalised Remittance Scheme and the money is converted to US dollars. Shares are held in your own name at Interactive Brokers LLC and are SIPC-insured up to $500,000 in total, including $250,000 for cash.

How much does one MiNK Therapeutics share cost in rupees?

One MiNK Therapeutics share is $12.14 — about ₹1,166 at a USD/INR rate of 96.07 on 28 Sep 2026. Both the MiNK Therapeutics price and the rupee rate move during the day, so the rupee cost changes with them.

What are the LRS and TCS rules for buying MiNK Therapeutics from India?

Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability. FX and the LRS declaration are handled by your bank when you fund your account.

Can I buy whole shares of MiNK Therapeutics?

Yes. One MiNK Therapeutics share is $12.14, and you can buy as many whole shares as you like. You can also buy by amount rather than by quantity: there is no minimum trade size, and Paasa supports fractional investing in MiNK Therapeutics.

How are gains on MiNK Therapeutics shares taxed in India?

The US does not levy capital gains tax on shares for Indian residents, so the tax is an India-side one. Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the USD/INR rate on the purchase and the sale date, so the rupee move counts alongside the MiNK Therapeutics price. Paasa issues a capital-gains statement for your return.

Does MiNK Therapeutics pay a dividend?

No. MiNK Therapeutics does not currently pay a dividend, so holding it produces no dividend income to declare in India. If it starts paying one, the Indian treatment is the usual one — dividends are taxed at your slab rate in India — and Paasa's dividend report would show the gross amount and any tax withheld.

When can I trade MiNK Therapeutics from India?

NASDAQ trades 7:00 pm – 1:30 am IST in Indian time, so the close lands after midnight. The window shifts to 8:00 pm – 2:30 am IST when the US is on standard time. Orders can only execute during that window.

Is there estate or inheritance tax on MiNK Therapeutics shares held from India?

US-situs assets such as US-listed shares can be exposed to US estate tax for non-US persons. It applies to your overall holdings in that jurisdiction rather than to any one position. Paasa's US estate tax calculator shows the exposure for a given portfolio value.

Do I have to declare MiNK Therapeutics shares in my Indian tax return?

Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. Paasa gives you a Schedule FA-ready statement listing your MiNK Therapeutics holding, its cost and its closing value.

How do I sell MiNK Therapeutics and bring the money back to India?

You sell during market hours (7:00 pm – 1:30 am IST) and the proceeds settle in USD in your Paasa account. From there you can hold the balance, reinvest, or repatriate. Funds can be withdrawn in any currency to any bank account in your own name. Whether the sale is short- or long-term is decided by the 24-month holding period.